Integrated BioPharma, Inc. (OTCMKTS:INBP – Get Free Report) was the target of a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 300 shares, a drop of 25.0% from the February 13th total of 400 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 32,600 shares, the days-to-cover ratio is currently 0.0 days.
Integrated BioPharma Price Performance
Shares of OTCMKTS INBP opened at $0.32 on Tuesday. The stock has a market capitalization of $9.60 million, a P/E ratio of 10.57 and a beta of 0.89. The company has a 50-day moving average price of $0.34 and a 200-day moving average price of $0.30. Integrated BioPharma has a 1 year low of $0.16 and a 1 year high of $0.42.
About Integrated BioPharma
Featured Articles
- Five stocks we like better than Integrated BioPharma
- How to Short Nasdaq: An Easy-to-Follow Guide
- Can TikTok Stock Picks Really Make You Rich?
- How to Invest in Biotech Stocks
- The “Quality” Rotation: Back to Basics Investing
- How to Start Investing in Real Estate
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.